Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CABANA-RAFT HF: Ablation vs Rate Control in AF and HFpEF
NCT07272902Recruiting
- Sponsor
- Nova Scotia Health
- Start
- Jan 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Randomised, open-label trial in Atrial fibrillation (AFib), heart failure with preserved ejection fraction (HFpEF) and heart failure with mildly reduced ejection fraction (HFmrEF) (2 arms), sponsored by Nova Scotia Health. Primary endpoint: Feasibility of Trial Conduct at 12 months. Started Jan 2026; status: recruiting.
02
Conditions
Atrial fibrillation (AFib)heart failure with preserved ejection fraction (HFpEF)heart failure with mildly reduced ejection fraction (HFmrEF)
Beyond the preview
Go deeper on NCT07272902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07272902.